Which has the lower trailing P/E, MNST or PFE?

PFE has the lower trailing P/E: MNST trades at 40.74 and PFE at 36.63. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, MNST or PFE?

Over the past five years, MNST grew revenue faster — MNST at a 12.36% CAGR versus PFE at 6.29%.

Does MNST or PFE pay a bigger dividend?

PFE pays a dividend (6.20% yield), while MNST is a former payer with no current dividend run rate.

Is MNST or PFE more profitable?

MNST runs the higher net margin — MNST at 23.08% versus PFE at 6.81%.

How have MNST and PFE total returns compared?

Over the past 10 years, MNST delivered 13.43% and PFE delivered 3.15% annualized total return. Past performance doesn't predict future results.

Monster Beverage Corporation (MNST) vs Pfizer Inc. (PFE)

A side-by-side comparison of Monster Beverage Corporation and Pfizer Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

Different business models: MNST is classified in Consumer Defensive; PFE is classified in Healthcare. Margin, capital intensity, and valuation differences should be interpreted in that sector context.

MNST

Monster Beverage Corporation

$86.46B

$44.20Consumer DefensiveDelayed quote: Sep 14, 2026, 4:00 PM EDT

PFE

Pfizer Inc.

$157.99B

$27.72HealthcareDelayed quote: Sep 14, 2026, 4:01 PM EDT

Total return — MNST vs PFE

growth of $100 · dividends reinvested · last 10y

MNST +255.7% (+13.5%/yr)PFE +37.0% (+3.2%/yr)MNST compounded faster over this window

MNST PFE

MNST vs PFE: by the numbers

•PFE is the larger company ($157.99B vs $86.46B market cap).
•PFE trades at the lower trailing earnings multiple (36.63 vs 40.74 P/E), one valuation lens rather than an overall verdict.
•MNST converts more revenue to profit (23.08% vs 6.81% net margin).
•MNST grew revenue faster over the past five years (12.36% vs 6.29% CAGR).
•PFE pays a dividend (6.20% yield), while MNST is a former payer with no current dividend run rate.

Metrics side by side

Valuation

Metric	MNST	PFE
P/E ratio	40.74	36.63
Forward P/E	38.09	9.32
P/S ratio	9.38	2.48
P/B ratio	9.23	1.85
EV / EBITDA	29.15	10.15
FCF yield	2.43%	6.95%

Profitability

Metric	MNST	PFE
Gross margin	55.55%	71.32%
Operating margin	29.16%	25.08%
Net margin	23.08%	6.81%
ROE	22.72%	5.09%
ROIC	21.32%	9.33%

Dividends

Metric	MNST	PFE
Dividend yield	N/A	6.20%
Payout ratio	N/A	227.27%

Growth (annualized)

Metric	MNST	PFE
Revenue CAGR (5Y)	12.36%	6.29%
EPS CAGR (5Y)	7.95%	-3.78%
FCF CAGR (5Y)	7.93%	-3.11%
Total return CAGR (5Y)	12.59%	-4.53%

Frequently asked

Which has the lower trailing P/E, MNST or PFE?: PFE has the lower trailing P/E: MNST trades at 40.74 and PFE at 36.63. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, MNST or PFE?: Over the past five years, MNST grew revenue faster — MNST at a 12.36% CAGR versus PFE at 6.29%.
Does MNST or PFE pay a bigger dividend?: PFE pays a dividend (6.20% yield), while MNST is a former payer with no current dividend run rate.
Is MNST or PFE more profitable?: MNST runs the higher net margin — MNST at 23.08% versus PFE at 6.81%.
How have MNST and PFE total returns compared?: Over the past 10 years, MNST delivered 13.43% and PFE delivered 3.15% annualized total return. Past performance doesn't predict future results.

Go deeper

Full MNST analysis Full PFE analysis Interactive comparison tool

Dig into the metrics

Monster Beverage P/E ratio Pfizer P/E ratio Pfizer dividend yield Monster Beverage ROE Pfizer ROE Monster Beverage operating margin Pfizer operating margin Monster Beverage revenue growth Pfizer revenue growth Monster Beverage free cash flow Pfizer free cash flow

Monster Beverage & Pfizer appear in these rankings

Highest Dividend Yield Stocks Highest ROIC Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.